Search results
Showing 31 to 39 of 39 results for polyps
Evidence-based recommendations on retrobulbar irradiation for thyroid eye disease. This involves using radiation to target the tissue behind the eyeball and reduce inflammation.
View recommendations for IPG148Show all sections
Sections for IPG148
Evidence-based recommendations on haemorrhoidal artery ligation. This involves tying the blood vessels and folding up the inside lining of the bowel to reduce blood supply to the haemorrhoids and make them shrink.
View recommendations for IPG342Show all sections
Sections for IPG342
of intrauterine pathologies such as submucosal fibroids and endometrial polyps. It also facilitates the fitting of...
NaviCam for diagnosing gastrointestinal tract conditions (MIB104)
NICE has developed a medtech innovation briefing (MIB) on NaviCam for diagnosing gastrointestinal tract conditions .
Chronic anal fissure: botulinum toxin type A injection (ESUOM14)
Summary of the evidence on botulinum toxin type A injection for treating chronic anal fissure to inform local NHS planning and decision-making
This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (DG28)
We have moved Diagnostics guidance 28 to become HealthTech guidance 438. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.
Molecular testing strategies for Lynch syndrome in people with colorectal cancer (HTG430)
Evidence-based recommendations on using immunohistochemistry or microsatellite instability testing to guide further testing for Lynch syndrome in people with colorectal cancer.